C4A and metabolic dysfunction-associated steatotic liver disease: The meta-analysis results showed that serum C4 levels in serum of patients with NAFLD were higher than those in the control group (MD: 0.04, 95% CI [0.02~0.07]) (I2 = 97%, P for heterogeneity < 0.00001).